82822:HK:HK-CSOP FTSE China A50 (CNY)

ETF | Others |

Last Closing

USD 10.21

Change

0.00 (0.00)%

Market Cap

USD 7.65B

Volume

0.40M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.22 (+1.21%)

USD 137.98B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+0.92 (+1.46%)

USD 22.56B
2801:HK iShares Core MSCI China ETF

+0.17 (+0.95%)

USD 13.97B
2823:HK iShares FTSE A50 China

+0.03 (+0.25%)

USD 13.65B
83188:HK ChinaAMC CSI 300 Index ETF

+0.16 (+0.49%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.01 (+1.27%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.10 (+1.29%)

USD 9.22B
9010:HK iShares Core MSCI AC Asia ex J..

+0.01 (+0.14%)

USD 3.03B
9846:HK iShares Core CSI 300

+0.01 (+0.47%)

USD 2.96B

ETFs Containing 82822:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.97% 64% D 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.97% 62% D 66% D+
Trailing 12 Months  
Capital Gain -13.11% 51% F 57% F
Dividend Return 2.89% 37% F 27% F
Total Return -10.21% 54% F 58% F
Trailing 5 Years  
Capital Gain -25.04% 29% F 66% D+
Dividend Return 9.10% 74% C 31% F
Total Return -15.93% 48% F 64% D
Average Annual (5 Year Horizon)  
Capital Gain -4.03% 55% F 51% F
Dividend Return -1.95% 59% D- 52% F
Total Return 2.09% 65% D 41% F
Risk Return Profile  
Volatility (Standard Deviation) 16.48% 55% F 79% B-
Risk Adjusted Return -11.82% 61% D- 50% F
Market Capitalization 7.65B 73% C 83% B

Annual Financials (CNY)

Quarterly Financials (CNY)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike